NCT04914975

Brief Summary

It has been reported that 62% of all people with Spinal Cord Injury (SCI) have experienced faecal incontinence and that neurogenic bowel dysfunction (NBD) is a major sequela. As an alternative to abdominal massage or the use of suppositories, the electrical stimulation (ES) of the abdominal wall has been shown to be effective in decreasing the bowel transit time as well as decreasing constipation in children with slow-transit constipation. Due to the intrinsic nature of the guts' innervation, we expect to reproduce these positive effects in people with SCI through administration of neuromuscular electrical stimulation (NMES).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 7, 2021

Completed
27 days until next milestone

Study Start

First participant enrolled

July 4, 2021

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2024

Completed
Last Updated

December 9, 2024

Status Verified

October 1, 2024

Enrollment Period

3.2 years

First QC Date

May 31, 2021

Last Update Submit

December 4, 2024

Conditions

Keywords

Spinal Cord InjuriesElectrical StimulationBowel ManagementTransit TimeIncontinenceQuality of Life

Outcome Measures

Primary Outcomes (1)

  • Neurogenic Bowel Dysfunction Score (NBDS) and the defaecation time from the stimulation protocol

    Investigation of the effect of NMES on the change in defaecation time (minutes) and its relation to the change in NBDS between the follow-up visits and baseline

    24 weeks

Secondary Outcomes (2)

  • Corn Test

    24 weeks; 5 time points

  • Bristol Stool Form Scale (BSFS)

    24 weeks; at each defaecation

Other Outcomes (3)

  • Qualiveen Short Form (SF)

    24 weeks; 5 times

  • International Standards to document remaining Autonomic Function after Spinal Cord Injury (ISAFSCI)

    24 weeks; 5 times

  • Questionnaire of treatment effectiveness

    24 weeks; 2 times

Study Arms (1)

NMES Group

EXPERIMENTAL

Participants will receive neuromuscular electrical stimulation of the abdominal wall before defaecation for 30 minutes over the course of 16 weeks.

Other: Neuromuscular electrical stimulation

Interventions

The stimulation will be conducted at home or at the SPC for half an hour about 30 minutes before the usual bowel emptying time. Four adhesive electrodes are attached to the abdominal wall for the neuromuscular electrical stimulation. The abdominal muscles are stimulated in such a way that activation occurs, i.e. the muscle alternately contracts and relaxes again. The stimulation sessions will be documented with a defined protocol. In addition, the stool consistency is rated according to the Bristol Stool Form Scale.

NMES Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Traumatic and non-traumatic SCI; \> 1 year
  • Level of lesion: C2 - L5
  • AIS score A/B/C/D
  • Age: ≥ 18 years
  • Urge to reduce defaecation time

You may not qualify if:

  • Patients during primary rehabilitation
  • Bladder stimulator
  • Autonomic dysreflexia by application of ES of the abdominal wall
  • Pregnancy: test in women of childbearing age (15 - 49 years)
  • Opioid use
  • Inflammatory bowel disease
  • Cancerous tissue in abdominal region
  • Patients' inability to follow the study, e.g. mental-health problems, language problems, dementia etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Swiss Paraplegic Centre

Nottwil, Canton of Lucerne, 6207, Switzerland

Location

Related Publications (5)

  • Korsten MA, Fajardo NR, Rosman AS, Creasey GH, Spungen AM, Bauman WA. Difficulty with evacuation after spinal cord injury: colonic motility during sleep and effects of abdominal wall stimulation. J Rehabil Res Dev. 2004 Jan-Feb;41(1):95-100. doi: 10.1682/jrrd.2004.01.0095.

    PMID: 15273902BACKGROUND
  • Krassioukov A, Eng JJ, Claxton G, Sakakibara BM, Shum S. Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord. 2010 Oct;48(10):718-33. doi: 10.1038/sc.2010.14. Epub 2010 Mar 9.

    PMID: 20212501BACKGROUND
  • Clarke MC, Catto-Smith AG, King SK, Dinning PG, Cook IJ, Chase JW, Gibb SM, Robertson VJ, Di Simpson, Hutson JM, Southwell BR. Transabdominal electrical stimulation increases colonic propagating pressure waves in paediatric slow transit constipation. J Pediatr Surg. 2012 Dec;47(12):2279-84. doi: 10.1016/j.jpedsurg.2012.09.021.

    PMID: 23217889BACKGROUND
  • Benevento BT, Sipski ML. Neurogenic bladder, neurogenic bowel, and sexual dysfunction in people with spinal cord injury. Phys Ther. 2002 Jun;82(6):601-12.

    PMID: 12036401BACKGROUND
  • Bersch I, Schafer K, Limacher A, Sonntag U, Baumberger M, Alberty M. The effect of neuromuscular electrical stimulation on bowel management in people with chronic spinal cord injury-An IDEAL 2a pilot study. Colorectal Dis. 2025 Nov;27(11):e70276. doi: 10.1111/codi.70276.

MeSH Terms

Conditions

Intestinal DiseasesSpinal Cord Injuries

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesSpinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Ines Bersch, PhD

    International FES Centre - Swiss Paraplegic Centre Nottwil

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: repeated measures interventional single subject design
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2021

First Posted

June 7, 2021

Study Start

July 4, 2021

Primary Completion

August 31, 2024

Study Completion

October 30, 2024

Last Updated

December 9, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations